UK cost agency backs drugs for preventing breast cancer
LONDON (Reuters) - British women with a family history of breast cancer could be offered two drugs to try to prevent the disease under draft guidelines published by the country's healthcare cost watchdog. Tamoxifen and raloxifene are already approved in the United States and other countries for preventing breast cancer in high-risk patients, but they have not so far been made available as preventative therapies in Britain. The new proposal by the National Institute for Health and Clinical Excellence (NICE) was welcomed by patient groups on Tuesday. ...
Source: news.yahoo.com
No comments:
Post a Comment